LOS ANGELES--(BUSINESS WIRE)--Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its ...

As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests. The team, which was funded by NIH's Rapid Acceleration of ...

LOS ANGELES--(BUSINESS WIRE)--Following a new investment of $6.1 million (NZD $8.8 million), biotech company Pictor today announced a partnership with U.S. laboratory service provider Mobility Health, ...

In a recent early release Pediatrics journal study, researchers investigate the presence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children between the ages ...

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. have formed a partnership to develop NanoSpot.AI, a fast, easy-to-administer SARS-CoV-2 antibody test. The University of Utah (the ...

As the world continues to learn how to live with Covid-19 in the long run, scientists are testing ways to quickly tell people how well-protected they are against the virus, and whether they need ...

Researchers have shown that commercially available rapid antigen tests can detect past and present variants of concern and have identified potential mutations that may impact test performance in the ...

There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States. A big concern has been test availability, but test accuracy may prove a larger long-term ...

Tests for the SARS virus will soon help doctors sort out whether people with worrisome coughs and fevers actually have the new respiratory illness, relieving anxiety for many and helping judge who ...

Monoclonal antibodies have been effective in treating in both preventing and treating SARS-CoV-2 infections. However, just as SARS-CoV-2 evolves to evade immune responses by vaccines and natural ...